Concordance between the test of the tuberculin and Interferon Gamma Release Assay-IGRA in patients with immune-mediated inflammatory diseases


Por: Catalan, I, Marti, C, Fortuno, M, Ramos, P, Vinals, P, Fernandez, M, Larrea, R, Martin, C, Blasco, J and Rincon, J

Publicada: 1 oct 2019
Resumen:
Introduction. The immunosuppressive therapies in the treatment of the immune-mediated inflammatory diseases (EIMI) predispose individuals to the tuberculosis, so the screening of latent tuberculosis infection (ITL) and the treatment reduces the likelihood of a progression to an active tuberculosis. The aim of the study was to analyze the concordance between the test of the tuberculin (PT) and "Interferon Gamma Release Assay-IGRA" in relation to the type of EIMI and the immunosuppressive treatment (IS). Material and methods. Transversal study of patients with EIMI candidates or in treatment IS forwarded to the ITL screening, from April 2017 until May 2018. The outcome variables were PT and IGRA. The explicative variables were: EIMI, IS, age, gender, prior BCG vaccination and tuberculosis risk factors. Results. A total of 146 patients were analyzed (33[22.69] vaccinated with BCG, 1 [0.7%] with a pre-diagnosis of tuberculosis, and 22 [15.1 0 4 from an endemic country). Kappa index (k) was 0,338 between PT and IGRA for the whole sample. A lower concordance was found in patients with the Crohn's disease (k=0.125), in the ones treated with corticosteroids (k=0.222), vaccinated with BCG (k=0.122) and in patients from tuberculosis endemic countries (k=0.128). Conclusion. The concordance between PT and IGRA is affected in patients with EIMI, and to a greater extent to patients with the inflammatory bowel disease, with the corticotherapy, with the BCG vaccination, or in the ones from endemic countries.

Filiaciones:
Catalan, I:
 Hosp Gen Univ Castellon, Med Interna, Avda Benicassim S-N, Castellon de La Plana, Spain

Marti, C:
 Hosp Gen Univ Castellon, Med Interna, Avda Benicassim S-N, Castellon de La Plana, Spain

Fortuno, M:
 Hosp Gen Univ Castellon, Microbiol, Castellon de La Plana, Spain

Ramos, P:
 Hosp Gen Univ Castellon, Med Prevent, Castellon de La Plana, Spain

Vinals, P:
 Hosp Clin Univ Valencia, Med Interna, Valencia, Spain

Fernandez, M:
 Hosp Gen Univ Castellon, Med Prevent, Castellon de La Plana, Spain

Larrea, R:
 Hosp Gen Univ Castellon, Med Prevent, Castellon de La Plana, Spain

Martin, C:
 Hosp Gen Univ Castellon, Med Prevent, Castellon de La Plana, Spain

Blasco, J:
 Hosp Gen Univ Castellon, Unidad Enfermedades Infecciosas, Castellon de La Plana, Spain

:
 Hosp Gen Univ Alicante, Med Interna, Alicante, Spain
ISSN: 02143429
Editorial
SOCIEDAD ESPANOLA QUIMIOTERAPIA, UNIV COMPLUTENSE MADRID, MICROBIOLOGY DEPT, SCHOOL MEDICINE, AVDA COMPLUTENSE S/N, MADRID, 28040, SPAIN, España
Tipo de documento: Article
Volumen: 32 Número: 5
Páginas: 445-450
WOS Id: 000510465000005
ID de PubMed: 31523944
imagen Open Access

MÉTRICAS